Prior to joining Synergetics, Mr Hable served as president and CEO of Afferent, a venture capital backed medical device company focused on neuro stimulation therapies. Previously, Mr Hable was chairman of the board of Oni Medical Systems.
Robert Dick, chairman of the board at Synergetics USA, said: “The appointment of David as CEO is an exciting and positive step forward for the company. David’s substantial experience and knowledge of the medical device industry will be invaluable to the continued growth of the company’s core businesses.
“His impressive record of executive level leadership at several medical device and healthcare companies coupled with his sales and marketing expertise, makes him the right executive to assume leadership of our company.”